DaShenLin Pharmaceutical Group Co., Ltd. (603233) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

DaShenLin Pharmaceutical Group Co., Ltd.

Why is DaShenLin Pharmaceutical Group Co., Ltd. ?

With ROE of 15.58%, it has a very attractive valuation with a 2.66 Price to Book Value

Over the past year, while the stock has generated a return of 33.74%, its profits have risen by 16.8% ; the PEG ratio of the company is 1
At the current price, the company has a high dividend yield of 3.6

Market Beating Performance

The stock has generated a return of 33.74% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to DaShenLin Pharmaceutical Group Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is DaShenLin Pharmaceutical Group Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

DaShenLin Pharmaceutical Group Co., Ltd.

11.28%

0.07

28.98%

China Shanghai Composite

15.17%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

14.62%

EBIT Growth (5y)

6.64%

EBIT to Interest (avg)

9.90

Debt to EBITDA (avg)

0.81

Net Debt to Equity (avg)

0.49

Sales to Capital Employed (avg)

1.65

Tax Ratio

27.74%

Dividend Payout Ratio

77.00%

Pledged Shares

Institutional Holding

ROCE (avg)

17.12%

ROE (avg)

16.57%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.66

EV to EBIT

13.96

EV to EBITDA

6.47

EV to Capital Employed

2.13

EV to Sales

0.86

PEG Ratio

1.01

Dividend Yield

3.62%

ROCE (Latest)

15.29%

ROE (Latest)

15.58%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 4,328.26 MM

RAW MATERIAL COST(Y)

Fallen by -9.41% (YoY

NET PROFIT(9M)

Higher at CNY 1,077.15 MM

CASH AND EQV(HY)

Highest at CNY 12,560.77 MM

DEBT-EQUITY RATIO (HY)

Lowest at 69.4 %

INVENTORY TURNOVER RATIO(HY)

Highest at 4.35 times

-2What is not working for the Company

OPERATING PROFIT(Q)

Lowest at CNY 441.63 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 6.75 %

Here's what is working for DaShenLin Pharmaceutical Group Co., Ltd.

Operating Cash Flow

Highest at CNY 4,328.26 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Cash and Eqv

Highest at CNY 12,560.77 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at 69.4 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio

Highest at 4.35 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Profit

Higher at CNY 1,077.15 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (CNY MM)

Raw Material Cost

Fallen by -9.41% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for DaShenLin Pharmaceutical Group Co., Ltd.

Operating Profit

Lowest at CNY 441.63 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 6.75 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales